Position in ROIV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$440,499
-$2,118,205 QoQ
Shares Held
12,447
-86.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#295
of 494 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Blackstone Inc. holds $252,665,757 across 52 Biotechnology names. ROIV ranks #37 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AUTL |
Autolus Therapeutics plc
|
20,485,611 | $32,776,977 | |
| 2 | DFTX |
Definium Therapeutics, Inc.
|
561,612 | $26,418,228 | |
| 3 | DMRA |
Damora Therapeutics, Inc.
|
1,002,971 | $26,087,275 | |
| 4 | ARTV |
Artiva Biotherapeutics, Inc.
|
2,403,437 | $23,313,338 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
237,108 | $22,565,568 | |
| 6 | ALXO |
Alx Oncology Holdings Inc
|
6,593,543 | $13,648,634 | |
| 7 | XFOR |
X4 Pharmaceuticals, Inc
|
2,681,922 | $12,524,575 | |
| 8 | IKT |
Inhibikase Therapeutics, Inc.
|
5,938,276 | $12,054,700 |
All Filings in ROIV
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $440,499 | 12,447 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $2,558,704 | 92,372 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $4,844,394 | 223,244 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $2,039,796 | 134,818 | Shares | Other | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||